Clinical Trial Update: The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months [Phase 3]

View source ↗

Summary

Phase 3 trial results report on the safety of a sumatriptan/naproxen combination formulation for treating multiple acute migraine episodes over 12 months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: POZEN | Conditions: Migraine Headaches | Phase 3 | Status: COMPLETED